Navigation Links
Cardiac Science Announces Third Quarter Results
Date:11/9/2009

----- ------- ----- Cost of Revenues: Products 49,261 48.5% 69,260 49.1% AED field initiative 18,500 16.1% - 0.0% Service 9,376 71.6% 9,557 67.7% ----- ---- ----- ---- Total cost of revenues 77,137 67.3% 78,817 50.8% ------ ---- ------ ---- Gross Profit: Products 33,803 33.3% 71,724 50.9% Service 3,722 28.4% 4,556 32.3% ----- ---- ----- ---- Gross profit 37,525 32.7% 76,280 49.2% ------ ---- ------ ---- Operating Expenses: Research and development 11,358 9.9% 11,762 7.6% Sales and marketing 34,392 30.0% 38,170 24.6% General and administrative 18,536 16.2% 15,568 10.0% ------ ----- ------ ----- Total operating expenses 64,286 56.1% 65,500 42.2% ------ ---- ------ ---- Operating income (loss) (26,761) -23.3% 10,780 7.0% ------- ----- ------ --- Other Income: Interest income 55 0.0% 434 0.3% Other income, net 555 0.5% 106 0.1% --- --- --- --- Total other income 610 0.5% 540 0.3% --- --- --- --- Income (loss) before income tax expense:
'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Personalized Medicine - The Genomic Revolution in Cardiac Care
2. FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function
3. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
4. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
5. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
6. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
7. Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
10. DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
11. Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... DIEGO , April 20, 2015  Halozyme ... company developing novel oncology and drug-delivery therapies, today ... the American Association for Cancer Research (AACR) annual ... results of its randomized Phase 2 study in ... annual meeting of the American Society of Clinical ...
(Date:4/20/2015)... PALO ALTO, Calif. , April 20, 2015 ... study demonstrate positive trends in the ability of ... slow the progression of amyotrophic lateral sclerosis (ALS, ... over a 6-month treatment period. While NP001,s slowing ... of the study was not statistically significant, clinically ...
(Date:4/20/2015)...  OpGen, Inc., a molecular testing and bioinformatics ... management team with the appointments of former Foundation ... Krenitsky , M.D. as president, and Timothy ... With more than 15 years ... biotechnology operations, including senior commercial and operational responsibilities ...
Breaking Medicine Technology:Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 2OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 3OpGen Appoints Industry Veterans Dr. Kevin Krenitsky as President and Timothy Dec as Interim Chief Financial Officer 4
(Date:4/20/2015)... 2015 “Consumers deserve to know that their ... children’s hair will not put their health at risk,” said ... National Alliance for Hispanic Health, the nation’s leading Hispanic health ... not had authority to ensure cosmetic and personal care products ... had authority to get products off the shelves if they ...
(Date:4/20/2015)... April 20, 2015 Goodreads is sponsoring ... Insurance: Why It’s Good for You and Your Company ... Zane Pilzer and Rick Lindquist have released a ... Why It’s Good for You and Your Company. The ... health insurance woes - employer-funded individual health insurance. ...
(Date:4/20/2015)... The normal response from the doctor used to be, ... Especially if the patient sought medical care after the six-hour ... different. So it’s critical the patient’s loved ones or caregiver ... , Not every emergency room physician or neurosurgeon has the ... But, according to Ronald P. Benitez , neurosurgeon and ...
(Date:4/20/2015)... Early registration is open for the 2nd ... at the start line. Returning to James Kealoha Beach ... to 500 participants (actually there’s only 499 spots since Big ... Now thru April 30, the entry fee is only $150 ... 1st, the fee goes up to $200 and $100, respectively. ...
(Date:4/20/2015)... Florida Hospital at Connerton Long Term ... from Select Medical, during the annual ceremony hosted at ... Chief Operating Officer, Debi Martoccio, received the Leadership Award ... of six recipients out of 113 hospitals nationwide. The ... for the contributions to the community as well as ...
Breaking Medicine News(10 mins):Health News:Statement of National Alliance for Hispanic Health on Senate Introduction of Personal Care Products Safety Act 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 3Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 2Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 3Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3
... , , RALEIGH ... SNN ; LSE: SN) Biologics & Spine is proceeding to ... of DUROLANE(R) Single Injection, Stabilized Hyaluronic Acid. , , ... and their global commercial partner, Smith & Nephew met today with ...
... , , , NEW YORK, Aug. ... the beauty industry is the naturals and organic market and HBA Global ... has obtained one of its most well-known innovators and activists to deliver ... the Special Events Hall of the Javits Center in New York. ...
... ... , ... 19, 2009 -- As parents across the country check off school items from their shopping ... season -- foot-friendly shoes. Whether on the school bus, in the classroom or on the ...
... , , , ELM GROVE, Wis., Aug. ... rgency D e partment Core Measures: A ... Comp i rion Healthcare Solutions to aid Hospital Emergency ... for AMI , CHA and CAP patients. Compliance with JCAHO ...
... Alahari, PhD, Associate Professor of Biochemistry and Molecular Biology at ... first time that a tiny piece of RNA appears to ... cancer and identified a gene that appears to inhibit invasive ... 2009 issue of the Journal of Biological Chemistry . ...
... for hand-held technologies , WEDNESDAY, Aug. 19 (HealthDay News) ... to smudge easily, but scientists say they have a ... of protective coatings, a finding that may lead to ... key to anti-smudge coatings is perfluoro alkyl ether, a ...
Cached Medicine News:Health News:Smith & Nephew Takes Single Injection PMA to Next Stage 2Health News:Smith & Nephew Takes Single Injection PMA to Next Stage 3Health News:Smith & Nephew Takes Single Injection PMA to Next Stage 4Health News:Horst M. Rechelbacher To Deliver HBA Global Expo Keynote Address 2Health News:Horst M. Rechelbacher To Deliver HBA Global Expo Keynote Address 3Health News:Give Shoes the '1,2,3 Test' During Back-To-School Shopping 2Health News:Give Shoes the '1,2,3 Test' During Back-To-School Shopping 3Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 2Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 3Health News:LSUHSC research discovers new targets for treatment of invasive breast cancer 2Health News:A Smudge-Free Smart Phone Screen? 2
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: